MRNA Moderna Inc
Company Analysis
Latest News
Moderna Seeks Global Approval for its mRNA-Based Seasonal Flu Vaccine
Moderna filed for marketing authorization for its seasonal influenza vaccine, mRNA-1010. The company submitted applications to the U.S. FDA, the European...
🟢 MRNA is trading 3.87% up today
MRNA is trading at +3.87% now at $30.63 amid a positive market open, moving in line with broader market strength. * No specific company news or...
🔴 MRNA is trading 3% down today
MRNA is trading 3.03% down at $29.49, aligning with broader market weakness observed across major indices. Broader market indices saw significant drops,...
Moderna Shares Decline Amid Post-Holiday Pullback; Analyst Sentiment Mixed
Moderna Inc. shares concluded the December 26 trading session at $31.20, down $1.55 (-4.73%), extending a post-holiday pullback. News flow over December 26-28...
🔴 MRNA is trading 3% down today
MRNA is trading at $31.74 (-3.08%) amid light post-Christmas holiday volume, with no major company-specific news explaining the drop. * The movement is...